EU Joint Programme – Neurodegenerative Disease Research (JPND)
Announcement: Multinational rapid-action call for expert Working Groups addressing the impact of COVID-19 on Neurodegenerative Disease Research
The EU Joint Programme – Neurodegenerative Disease Research (JPND) has launched a multinational rapid-action call for expert Working Groups addressing the impact of COVID-19 on Neurodegenerative Diseases research.
JPND launched a call for leading scientists in the field to establish community-led Working Groups dedicated to discuss research strategies that concern the impact of COVID-19 on the development and progression of neurodegenerative disease as well as on the care of patients suffering from neurodegenerative diseases. These strategies can also consider the impact of COVID-19 on neurodegenerative disease research itself, how it is conducted and how it influenced technological innovations for neurodegenerative diseases.
This call will not fund direct research activities. Instead, Working Groups will be funded for up to 9 months with 50.000€ each to cover their expenses (e.g. meetings and travel costs). They must provide outputs of value to the broader research community, e.g. best-practice guidelines, methodological frameworks or foresight publications.
CIHR Institute of Aging will support one Working Group relevant to any area of the call and the Public Health Agency of Canada will support one Working Group on methods and sources of data to enable or improve the surveillance of the impacts of COVID-19 as they relate to the development or progression of neurodegenerative diseases.
This will be a one-step call, submission deadline is December 14, 2021.
- Date modified: